CatalystFDA/Bio

Bristol-Myers Squibb: Patent Cliff Is Still A Problem

Bristol-Myers Squibb faces patent cliff concerns per Seeking Alpha analysis.

What changed

Bristol-Myers Squibb faces patent cliff concerns per Seeking Alpha analysis.

Why it matters

Bristol-Myers Squibb faces patent cliff concerns per Seeking Alpha analysis. — impact context not separately stored; see What changed.

Sources